Laddar...
Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19
BACKGROUND: The clinical course of severe COVID-19 in cystic fibrosis (CF) is incompletely understood. We describe the use of alpha-1 antitrypsin (AAT) as a salvage therapy in a critically unwell patient with CF (PWCF) who developed COVID-19 while awaiting lung transplantation. METHODS: IV AAT was a...
Sparad:
| I publikationen: | J Cyst Fibros |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7678455/ https://ncbi.nlm.nih.gov/pubmed/33288475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2020.11.012 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|